000			01453 a2200313 4500
005			20250515131309.0
264		0	_c20081028
008			200810s 0 0 eng d
022			_a1699-048X
024	7		_a10.1007/s12094-008-0234-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aRodríguez Lajusticia, Laura
245	0	0	_aEndocrine therapy of metastatic breast cancer. _h[electronic resource]
260			_bClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _cAug 2008
300			_a462-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAntineoplastic Agents, Hormonal _xtherapeutic use
650	0	4	_aAromatase Inhibitors _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aClinical Trials as Topic
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aNeoplasms, Hormone-Dependent _xdrug therapy
650	0	4	_aReceptors, Estrogen _xantagonists & inhibitors
700	1		_aMartín Jiménez, Miguel
700	1		_aLópez-Tarruella Cobo, Sara
773	0		_tClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico _gvol. 10 _gno. 8 _gp. 462-7
856	4	0	_uhttps://doi.org/10.1007/s12094-008-0234-5 _zAvailable from publisher's website
999			_c18143895 _d18143895